{"id":"https://openalex.org/W3097181513","doi":"https://doi.org/10.1182/blood-2020-137005","title":"Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy","display_name":"Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3097181513","doi":"https://doi.org/10.1182/blood-2020-137005","mag":"3097181513"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-137005","doi":"https://doi.org/10.1182/blood-2020-137005","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137005","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8330207","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073739738","display_name":"Daniel I. Nathan","orcid":"https://orcid.org/0000-0003-4186-7412","observed_orcids":["https://orcid.org/0000-0003-4186-7412"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel I. Nathan","raw_affiliation_strings":["Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085185312","display_name":"Douglas A. Tremblay","orcid":"https://orcid.org/0000-0002-4719-7192","observed_orcids":["https://orcid.org/0000-0002-4719-7192","https://orcid.org/0000-0003-2584-6953"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Tremblay","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076589550","display_name":"Santiago Thibaud","orcid":"https://orcid.org/0000-0001-8454-5136","observed_orcids":["https://orcid.org/0000-0001-8454-5136"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Santiago Thibaud","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072336042","display_name":"John O Mascarenhas","orcid":"https://orcid.org/0000-0002-8400-0483","observed_orcids":["https://orcid.org/0000-0002-8400-0483"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Mascarenhas","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062295987","display_name":"Janice Lynn Gabrilove","orcid":"https://orcid.org/0000-0002-2967-4493","observed_orcids":["https://orcid.org/0000-0002-2967-4493"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janice L. Gabrilove","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"136","issue":"Supplement 1","first_page":"30","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.7890999913215637,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.1876000016927719,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9909999966621399},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9419999718666077},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9959999918937683},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.8989999890327454},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":1.0},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9909999966621399},{"id":"https://openalex.org/keywords/treatment-interruption","display_name":"treatment interruption","score":0.5410000085830688},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7350000143051147},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7870000004768372},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.8980000019073486},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.9089999794960022},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9810000061988831},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.8109999895095825},{"id":"https://openalex.org/keywords/cytokine-response","display_name":"cytokine response","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9131653308868408},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8707007169723511},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.7287639379501343},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7180122137069702},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.6434767246246338},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.637212872505188},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6012165546417236},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.4432961046695709},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43332844972610474},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.4123360514640808},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3535071015357971},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.15970340371131897},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2020-137005","doi":"https://doi.org/10.1182/blood-2020-137005","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137005","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8330207","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8330207","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8330207","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8330207","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3037811810","https://openalex.org/W3037784318","https://openalex.org/W6922570957","https://openalex.org/W3037781209","https://openalex.org/W3045914984","https://openalex.org/W4411468133","https://openalex.org/W4220668224","https://openalex.org/W4310679927","https://openalex.org/W3136245411","https://openalex.org/W6943535868"],"abstract_inverted_index":{"Introduction":[0],"The":[1,73,164],"ongoing":[2],"novel":[3],"coronavirus":[4],"disease":[5],"2019":[6],"(COVID-19)":[7],"pandemic":[8],"has":[9,54],"provoked":[10],"questions":[11],"about":[12],"treatment":[13],"decisions":[14],"in":[15,70,227,271,280,311,321,328,406,448,450,493],"patients":[16,77,111,133,203,233,239,252,295,333,351,411,449,494],"with":[17,84,112,117,122,145,152,210,318,389,412,461,495,499],"hematologic":[18,113,413,496],"malignancies.":[19],"Of":[20,250,293],"note,":[21],"several":[22],"anti-cancer":[23,491],"agents":[24,44,80,98,119,168],"have":[25,29,59],"been":[26,56],"shown":[27,57],"to":[28,58,67,193,434,470],"preclinical":[30],"activity":[31,61,440],"against":[32,62],"the":[33,42,63,94,100,159,186,251,272,281,285,294,312,322,329,382,472],"SARS-CoV-2":[34,155],"virus,":[35],"including":[36,278],"ruxolitinib":[37,53,207,236,313,403,452,475],"(Jakafi),":[38],"as":[39,41],"well":[40],"hypomethylating":[43],"(HMA)":[45],"decitabine":[46,149],"(Dacogen)":[47],"and":[48,88,137,179,222,230,237,246,263,284,302,324,367,404,478,509,522],"azacitidine":[49,245],"(Vidaza).":[50],"In":[51],"addition,":[52],"previously":[55],"potent":[60],"cytokine":[64],"response,":[65],"similar":[66],"that":[68],"seen":[69],"COVID-19":[71,85,153,194,211,261],"infections.":[72],"optimal":[74],"management":[75],"of":[76,96,103,110,131,361,410,416,427,474,490],"on":[78,204,241,244,248,253,267,296,376,379],"these":[79,97,118,167,442],"who":[81,141,183,334,352,453],"become":[82],"infected":[83,121],"is":[86,90],"unknown":[87],"it":[89],"not":[91,370,387],"clear":[92],"if":[93],"use":[95,473,489],"modifies":[99],"clinical":[101,223,468],"course":[102],"infection.":[104,308],"We":[105,125],"describe":[106],"a":[107,127],"case":[108],"series":[109],"malignancies":[114],"receiving":[115,143,235,451],"therapy":[116,144,257,290,300,418,492],"while":[120],"COVID-19.":[123,500],"Methods":[124],"conducted":[126],"retrospective":[128],"chart":[129],"review":[130],"consecutive":[132],"between":[134],"March":[135],"1":[136],"May":[138],"21,":[139],"2020":[140],"were":[142,196,208,234,240,304,375,386,399],"ruxolitinib,":[146,297],"azacitidine,":[147],"or":[148,206,345,391],"when":[150],"diagnosed":[151,209,498],"by":[154],"PCR":[156],"assay":[157],"within":[158,212],"Mount":[160],"Sinai":[161],"Health":[162],"System.":[163],"indications":[165],"for":[166,288,381,401,441],"included":[169],"acute":[170,173],"lymphocytic":[171],"leukemia,":[172,175],"myeloid":[174],"myelofibrosis,":[176],"polycythemia":[177],"vera,":[178],"myelodysplastic":[180],"syndromes.":[181],"Patients":[182],"last":[184],"received":[185],"agent":[187],"more":[188],"than":[189,364],"thirty":[190],"days":[191],"prior":[192],"diagnosis":[195],"excluded":[197],"from":[198],"our":[199,213,464],"series.":[200],"Results":[201],"Sixteen":[202],"HMA":[205,273,405,421],"health":[214],"system":[215],"during":[216],"this":[217,407,457],"span.":[218],"Full":[219],"patient":[220,287],"characteristics":[221],"data":[224,482],"are":[225,476,479],"described":[226],"Tables":[228],"1a":[229],"1b.":[231],"Seven":[232],"nine":[238],"HMA:":[242],"eight":[243,255],"one":[247,264,286,368],"decitabine.":[249],"HMA,":[254],"had":[256,299],"held":[258,301,424],"after":[259,306],"confirmed":[260,307],"infection,":[262],"was":[265,275,291,315,419,422,445],"continued":[266,305,454],"therapy.":[268],"Overall":[269,309],"mortality":[270,310,327,390,397],"cohort":[274,314],"88.9%":[276],"(8/9),":[277],"7/8":[279],"therapy-held":[282,323],"group":[283,384,409],"whom":[289],"continued.":[292],"three":[298],"four":[303],"57.1%":[316],"(4/7),":[317],"75%":[319],"(3/4)":[320],"33%":[325],"(1/3)":[326],"therapy-continued":[330],"groups.":[331],"All":[332],"died":[335],"(n":[336,354],"=":[337,355],"12)":[338],"required":[339,357],"either":[340],"non-invasive":[341],"positive":[342],"pressure":[343],"ventilation":[344],"mechanical":[346],"ventilation.":[347],"Across":[348],"all":[349],"agents,":[350],"survived":[353],"4)":[356],"no":[358],"higher":[359,378],"level":[360],"supplemental":[362],"oxygen":[363,393],"non-rebreather":[365],"mask,":[366],"did":[369],"require":[371],"hospitalization.":[372],"Cytokine":[373],"levels":[374],"average":[377],"admission":[380],"ruxolitinib-held":[383],"but":[385],"associated":[388],"increased":[392],"requirement.":[394],"Discussion":[395],"High":[396],"rates":[398],"observed":[400],"both":[402],"high-risk":[408],"malignancy":[414,497],"regardless":[415],"whether":[417],"held.":[420],"commonly":[423],"at":[425],"time":[426],"infection:":[428],"further":[429,486],"investigation":[430,487],"will":[431],"be":[432,459],"needed":[433],"elucidate":[435],"any":[436],"potential":[437],"in-vivo":[438],"anti-SARS-CoV-2":[439],"reagents.":[443],"Mortality":[444],"numerically":[446],"less":[447],"therapy,":[455],"however":[456],"should":[458],"interpreted":[460],"caution":[462],"given":[463],"small":[465],"cohort.":[466],"Further":[467],"trials":[469],"address":[471],"necessary":[477],"ongoing.":[480],"These":[481],"can":[483],"help":[484],"guide":[485],"regarding":[488],"Disclosures":[501],"Mascarenhas:":[502],"Celgene,":[503],"Prelude,":[504],"Galecto,":[505],"Promedior,":[506,515],"Geron,":[507],"Constellation,":[508],"Incyte:":[510],"Consultancy;":[511],"Incyte,":[512],"Kartos,":[513],"Roche,":[514],"Merck,":[516],"Merus,":[517],"Arog,":[518],"CTI":[519],"Biopharma,":[520],"Janssen,":[521],"PharmaEssentia:":[523],"Other:":[524],"Research":[525],"funding":[526],"(institution).":[527]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-11-09T00:00:00"}